Glucose Metabolism by Escherichia coli Inhibits Vibrio cholerae Intestinal Colonization of Zebrafish
The O1 serogroup is responsible for pandemic cholera and is divided into the classical and El Tor biotypes. Classical produces acid when using glucose as a carbon source, whereas El Tor produces the neutral product acetoin when using glucose as a carbon source. An earlier study demonstrated that str...
Gespeichert in:
Veröffentlicht in: | Infection and immunity 2018-12, Vol.86 (12) |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The
O1 serogroup is responsible for pandemic cholera and is divided into the classical and El Tor biotypes. Classical
produces acid when using glucose as a carbon source, whereas El Tor
produces the neutral product acetoin when using glucose as a carbon source. An earlier study demonstrated that
strains that metabolize glucose to acidic by-products drastically reduced the survival of
strains
In the present study, zebrafish were fed 1% glucose and either inoculated with single
or
strains or coinfected with both
and
A significant decrease in classical biotype colonization was observed after glucose feeding due to acid production in the zebrafish intestine. El Tor colonization was unaffected by glucose alone. However, the El Tor strain exhibited significantly lower colonization of the zebrafish when either of the acid-producing
strains was coinoculated in the presence of glucose. An
sugar transport mutant had no effect on
colonization even in presence of glucose. Glucose and
produced a prophylactic effect on El Tor colonization in zebrafish when
was inoculated before
infection. Thus, the probiotic feeding of
inhibits
colonization in a natural host. This suggests that a similar inhibitory effect could be seen in cholera patients, especially if a glucose-based oral rehydration solution (ORS) is administered in combination with probiotic
during cholera treatment. |
---|---|
ISSN: | 0019-9567 1098-5522 |
DOI: | 10.1128/iai.00486-18 |